Literature DB >> 18184168

Surgical treatment for stress urinary incontinence.

Chris K Harding1, Andrew C Thorpe.   

Abstract

The prevalence of stress urinary incontinence is quite significant with large numbers of women affected. Many of these women will not seek medical help in the belief that they will not be cured or improved. With the increasing numbers of procedures now available we present a review of both established and novel surgical techniques that is intended to help both urologists and primary care physicians in the counselling of patients complaining of stress incontinence. We compare the "gold standards" of surgical treatment for all types of stress incontinence with the newer techniques that have recently become popular among urologists and gynaecologists.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184168     DOI: 10.1111/j.1442-2042.2007.01918.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  4 in total

Review 1.  Survey on surgery for stress urinary incontinence in an era mid-urethral slings are being questioned.

Authors:  An-Sofie D'hulster; Susanne Housmans; Wilbert Spaans; Frank Van der Aa; Koen Slabbaert; Alfred L Milani; Jan Deprest
Journal:  Int Urogynecol J       Date:  2019-12-17       Impact factor: 2.894

2.  Treatment of moderate to severe female stress urinary incontinence with the adjustable continence therapy (ACT) device after failed surgical repair.

Authors:  Sherif R Aboseif; Pejvak Sassani; Ethan I Franke; Steven D Nash; Joel N Slutsky; Neil H Baum; Mai Le Tu; Niall T Galloway; Peter J Pommerville; Suzette E Sutherland
Journal:  World J Urol       Date:  2010-10-20       Impact factor: 4.226

Review 3.  Transvaginal retropubic sling systems: efficacy and patient acceptability.

Authors:  Christina P Moldovan; Michelle E Marinone; Andrea Staack
Journal:  Int J Womens Health       Date:  2015-02-16

Review 4.  Burch colposuspension.

Authors:  Nikolaus Veit-Rubin; Jean Dubuisson; Abigail Ford; Jean-Bernard Dubuisson; Sherif Mourad; Alex Digesu
Journal:  Neurourol Urodyn       Date:  2019-01-08       Impact factor: 2.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.